{"id":"standard-empirical-antimicrobial-treatment-discontinuation","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This represents a therapeutic strategy or clinical guideline for de-escalation of antimicrobial treatment in hospitalized patients, rather than a specific drug entity. It involves stopping or narrowing empirical antibiotic coverage when clinical and microbiological criteria are met, reducing unnecessary antibiotic exposure and supporting antimicrobial stewardship.","oneSentence":"This is a clinical protocol for discontinuing empirical broad-spectrum antimicrobial therapy based on standardized criteria rather than a pharmacological drug.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:09:14.876Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"De-escalation of empirical antimicrobial therapy in hospitalized patients with suspected or confirmed infections"}]},"trialDetails":[{"nctId":"NCT07051525","phase":"NA","title":"Early Versus Late Stopping of Antibiotics in Adults With High-risk Hematological Malignancies/Receiving Cellular Therapies and Fever","status":"RECRUITING","sponsor":"Peter MacCallum Cancer Centre, Australia","startDate":"2025-12-03","conditions":"Leukemia, CART Therapy, Transplantation, Stem Cell","enrollment":214},{"nctId":"NCT06100614","phase":"NA","title":"Presepsin to Safely Reduce Antibiotics in Preterm Infants","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2024-09-23","conditions":"Early-Onset Neonatal Sepsis","enrollment":900},{"nctId":"NCT06238297","phase":"NA","title":"Rapid De-escalation of Anti-MRSA Therapy Guided by S. Aureus Nares Screening in Case of Pneumonia","status":"RECRUITING","sponsor":"University of Bari Aldo Moro","startDate":"2024-05-06","conditions":"Pneumonia, Bacterial","enrollment":76},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT03360851","phase":"NA","title":"DiagNostic Study of Low-dose CT and multipleX PCR on Antibiotic Treatment and Outcome of Community-Acquired Pneumonia","status":"TERMINATED","sponsor":"MJM Bonten","startDate":"2017-11-27","conditions":"Community-acquired Pneumonia","enrollment":3555},{"nctId":"NCT01581333","phase":"PHASE4","title":"Study to Reduce Duration of Antibiotic Therapy in Haematological Patients With Fever and Neutropenia","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2012-04","conditions":"Febrile Neutropenia","enrollment":157},{"nctId":"NCT00407147","phase":"PHASE4","title":"Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection","status":"TERMINATED","sponsor":"Brahms AG","startDate":"2008-07","conditions":"Infection, Bacterial Infection, Sepsis","enrollment":11}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Laboratory rules for finalization of antimicrobial therapy"],"phase":"marketed","status":"active","brandName":"Standard empirical antimicrobial treatment discontinuation","genericName":"Standard empirical antimicrobial treatment discontinuation","companyName":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","companyId":"fundaci-n-p-blica-andaluza-para-la-gesti-n-de-la-investigaci-n-en-sevilla","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a clinical protocol for discontinuing empirical broad-spectrum antimicrobial therapy based on standardized criteria rather than a pharmacological drug. Used for De-escalation of empirical antimicrobial therapy in hospitalized patients with suspected or confirmed infections.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}